Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UNIFI: Ustekinumab in Ulcerative Colitis
NCT02407236Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2015
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 23
01
Overview
A Phase 3 trial of ustekinumab in ulcerative colitis (UC), sponsored by Janssen Pharmaceutical. Started Jul 2015; status: completed.
02
Drugs
ustekinumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02407236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407236.